# FDA 483 - Colgate-Palmolive Company - May 30, 2019

Source: https://www.globalkeysolutions.net/records/483/colgate-palmolive-company/62186d39-57c7-438a-aae3-42bd3b0eda0c

> FDA 483 for Colgate-Palmolive Company on May 30, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Colgate-Palmolive Company
- Inspection Date: 2019-05-30
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: The FDA inspected Colgate Palmolive Company's Corporate Headquarters in Piscataway, NJ, and issued a Form 483 with one observation. The firm failed to submit copies of product labels with serious adverse event reports for OTC Monograph non-prescription drugs. This indicates a deficiency in their adverse event reporting process.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)
- [Regulatory Officer](https://www.globalkeysolutions.net/people/peter-r-lenahan/c695dac2-5447-434b-801e-f95e6acf05f1)

Company: https://www.globalkeysolutions.net/companies/colgate-palmolive-company/99f3eb72-f684-485c-8cc0-c9d4c701ba8c

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248